Clinical Trials Directory

Trials / Sponsors / Immorna Biotherapeutics, Inc.

Immorna Biotherapeutics, Inc.

Industry · 7 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingOne Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid
Malignant Solid Tumors
Phase 1 / Phase 22026-03-18
Active Not RecruitingA Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine
Herpes Zoster (HZ), Infectious Diseases, Shingles
Phase 22024-10-16
Active Not RecruitingA Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
Respiratory Syncytial Virus (RSV), Infectious Disease
Phase 12024-09-25
CompletedA First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
Herpes Zoster (HZ), Shingles, Infectious Disease
Phase 12023-05-26
CompletedA Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19
COVID-19, Infectious Disease
Phase 12023-03-07
CompletedStudy to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Cutaneous Tumor, Malignant Solid Tumor
Phase 12023-02-24
UnknownStudy to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors
Cutaneous Tumor, Malignant Solid Tumor
Phase 12022-10-18